| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.05 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |